Welcome to Central Library, SUST

Successful drug discovery / (Record no. 65393)

MARC details
000 -LEADER
fixed length control field 04710cam a2200637Ii 4500
001 - CONTROL NUMBER
control field sulb-eb0033741
003 - CONTROL NUMBER IDENTIFIER
control field BD-SySUS
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20170713221416.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu|||unuuu
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 150223s2015 gw ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency DG1
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency DG1
Modifying agency IDEBK
-- COO
-- CDX
-- OCLCF
-- RECBK
-- OCLCQ
-- DEBBG
-- EBLCP
-- BD-SySUS
019 ## -
-- 903317911
-- 904961652
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783527678433
Qualifying information (electronic bk.)
International Standard Book Number 3527678433
Qualifying information (electronic bk.)
International Standard Book Number 1322949557
Qualifying information (ebk)
International Standard Book Number 9781322949550
Qualifying information (ebk)
International Standard Book Number 9783527678457
Qualifying information (electronic bk.)
International Standard Book Number 352767845X
Qualifying information (electronic bk.)
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/9783527678433
Source of number or code doi
028 01 - PUBLISHER NUMBER
Publisher number EB00596207
Source Recorded Books
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier NZ1
System control number 15914892
OCLC library identifier DEBBG
System control number BV043397534
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)903897512
Canceled/invalid control number (OCoLC)903317911
-- (OCoLC)904961652
037 ## - SOURCE OF ACQUISITION
Stock number 726237
Source of stock number/acquisition MIL
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RS420
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1/9
Edition number 23
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Successful drug discovery /
Statement of responsibility, etc. edited by János Fischer and David P. Rotella.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Weinheim, Germany :
Name of producer, publisher, distributor, manufacturer Wiley-VCH,
Date of production, publication, distribution, manufacture, or copyright notice 2015.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Part I: General Aspects. Serendipitous Target-Based Drug Discoveries / János Fischer, David P Rotella -- Drug Discoveries and Molecular Mechanism of Action / David C Swinney -- Part II: Drug Class. Insulin Analogs -- Improving the Therapy of Diabetes / John M Beals -- Part III: Case Histories. The Discovery of Stendra (Avanafil) for the Treatment of Erectile Dysfunction / Koichiro Yamada, Toshiaki Sakamoto, Kenji Omori, Kohei Kikkawa -- Dapagliflozin, A Selective SGLT2 Inhibitor for Treatment of Diabetes / William N Washburn -- Elvitegravir, A New HIV-1 Integrase Inhibitor for Antiretroviral Therapy / Hisashi Shinkai -- Discovery of Linagliptin for the Treatment of Type 2 Diabetes Mellitus / Matthias Eckhardt, Thomas Klein, Herbert Nar, Sandra Thiemann -- The Discovery of Alimta (Pemetrexed) / Edward C Taylor -- Perampanel: A Novel, Noncompetitive AMPA Receptor Antagonist for the Treatment of Epilepsy / Shigeki Hibi -- Discovery and Development of Telaprevir (Incivek): A Protease Inhibitor to Treat Hepatitis C Infection / Bhisetti G Rao, Mark Murcko, Mark J Tebbe, Ann D Kwong -- Antibody-Drug Conjugates: Design and Development of Trastuzumab Emtansine (T-DM1) / Sandhya Girish, Gail D Lewis Phillips, Fredric S Jacobson, Jagath R Junutula, Ellie Guardino.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Online resource; title from PDF title page (John Wiley, viewed February 23, 2015).
520 ## - SUMMARY, ETC.
Summary, etc. The first volume of the book series "Successful Drug Discovery" is focusing on new drug discoveries during the last decade, from established drugs to recently introduced drugs of all kinds:small-molecule-, peptide-, and protein-based drugs. The role of serendipity is analyzed in some very successful drugs where the research targets of the lead molecule and the drug are different. Phenotypic and target-based drug discovery approaches are discussed from the viewpoint of pioneer drugs and analogues. This volume gives an excellent overview of insulin analogues including a discussion of the properties of rapid-acting andlong-acting formulations of this important hormone. The major part of the book is devoted to case histories of new drug discoveries described by their key inventors. Eight case histories range across many therapeutic fields. The goal of this book series is to help the participants of thedrug research community with a reference book series and to support teaching in medicinal chemistry with case histories and review articles of new drugs.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Design.
Topical term or geographic name as entry element Pharmaceutical chemistry.
Topical term or geographic name as entry element Medical.
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacology.
Source of heading or term bisacsh
Topical term or geographic name as entry element Drugs
General subdivision Design.
Source of heading or term fast
Authority record control number (OCoLC)fst00898790
Topical term or geographic name as entry element Pharmaceutical chemistry.
Source of heading or term fast
Authority record control number (OCoLC)fst01060115
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fischer, János,
Relator term editor.
Personal name Rotella, David P.,
Relator term editor.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
International Standard Book Number 9783527678433
Record control number (OCoLC)903897512
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://onlinelibrary.wiley.com/book/10.1002/9783527678433">http://onlinelibrary.wiley.com/book/10.1002/9783527678433</a>
Public note Wiley Online Library [Free Download only for SUST IP]
938 ## -
-- Ingram Digital eBook Collection
-- IDEB
-- cis35639447
-- EBL - Ebook Library
-- EBLB
-- EBL4044562
-- Coutts Information Services
-- COUT
-- 30970594
-- Ingram Digital eBook Collection
-- IDEB
-- cis30970594
-- Recorded Books, LLC
-- RECE
-- rbeEB00596207
994 ## -
-- 92
-- DG1

No items available.